Korea’s No.1 pharmaceutical company Dong-A Pharm broke ground on Thursday to produce biosimilars in Songdo, Incheon, marking the company’s first step toward fostering biosimilars as a new growth engine.
The ground-breaking ceremony in Incheon’s free economic zone was attended by 100 officials including Kang Shin-ho, the company’s chairman, Masahiko Matsuo, president of Japan’s Meiji Seika Ph...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.